|
|
|||||||
Thalassemia Syndrome |
1 Genomic Unit for the Diagnosis of Human Pathologies and
4 Obstetrics and Gynecology, San Raffaele Scientific Institute, Milan;
2 Ospedale Maggiore Policlinico Mangiagalli Regina Elena, Milan;
3 Department of Clinical Pathology, A.O.O.I.R.M. S. Anna, Torino;
5 Università Vita-Salute San Raffaele, Milan and
6 Diagnostica e Ricerca San Raffaele SpA, Milan, Italy
Correspondence: Laura Cremonesi, Genomic Unit for the Diagnosis of Human Pathologies, San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy. E-mail: cremonesi.laura{at}hsr.it
The presence of fetal DNA in maternal plasma can be exploited to develop new procedures for non-invasive prenatal diagnosis. Tests to detect 7 frequent β-globin gene mutations in people of Mediterranean origin were applied to the analysis of maternal plasma in couples where parents carried different mutations. A mutant enrichment amplification protocol was optimized by using peptide nucleic acids (PNAs) to clamp maternal wild-type alleles. By this approach, 41 prenatal diagnoses were performed by microelectronic microchip analysis, with total concordance of results obtained on fetal DNA extracted from chorionic villi. Among these, 27/28 were also confirmed by direct sequencing and 4 by pyrosequencing.
Key words: non-invasive prenatal diagnosis, fetal DNA in maternal plasma, PNA-clamping.
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |